*Completing the assessment on the Harper Meds website does not establish a doctor-patient relationship between the individual and Harper Meds. Beluga Health, a network of US-licensed physicians committed to rigorous medical protocols to ensure patient safety, has set exclusionary criteria to identify whether an individual is ineligible for Semaglutide. The responses provided in the Harper Meds assessment will determine if an individual is considered excluded or non-excluded. Harper Meds serves as a facilitator, connecting non-excluded individuals with Beluga Health and its clinicians. The decision to prescribe compounded Semaglutide lies solely with Beluga Health clinicians, thereby forming the doctor-patient relationship with those seeking a prescription.

Any claims and benefits mentioned on this website are based on studies of non-compounded versions of Semaglutide. Results from the compounded medications available through the Harper Meds platform may vary. These compounded medications, including Semaglutide, are manufactured in FDA-licensed 503A Outsourcing Facilities. Although these facilities are subject to stringent regulation, the medications themselves are not FDA-approved, as they are tailored to individual prescriptions for specific patients. The decision to use compounded medications is based on the licensed provider’s medical judgment, informed by a telehealth consultation and the patient’s medical history.

We advise all potential users of compounded Semaglutide to discuss the particular risks and benefits of compounded medications with their healthcare provider. As Harper Meds is not involved in the production of compounded Semaglutide, the medication you receive may differ in appearance from what is depicted on the website.*